Neurocrine Biosciences, Inc.
NasdaqGS:NBIX
Sector
Location
Market Cap
USD 12.40 B
Share Price
USD 125.01
Avg Daily Volume
1,000,396
Change (1 day)
-0.47%
Change (1 year)
-14.80%
Change (YTD)
-8.42%
Neurocrine Biosciences, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 529.90 M
Neurocrine Biosciences, Inc. Operating Cash Flow is USD 529.90 M for the Trailing 12 Months (TTM) ending March 31, 2025, a -17.90% change year over year. Operating cash flow is cash generated from the company’s regular business operations.
-
Neurocrine Biosciences, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 645.40 M, a 153.40% change year over year.
-
Neurocrine Biosciences, Inc. Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 254.70 M.
StockViz
Competitors
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
Corcept Therapeutics Incorporated
USD 72.30
CORT
+0.82
1.15%
Jazz Pharmaceuticals plc
USD 111.30
JAZZ
-0.78
-0.70%
SK Biopharmaceuticals Co., Ltd.
USD 71.31
326030.KS
-0.30
-0.42%
H. Lundbeck A/S
USD 5.44
HLUN-B.CO
+0.01
0.19%
Axsome Therapeutics, Inc.
USD 104.80
AXSM
+0.48
0.46%
Alkermes plc
USD 26.71
ALKS
+0.11
0.41%
ACADIA Pharmaceuticals Inc.
USD 24.60
ACAD
+0.20
0.82%
Indivior PLC
USD 22.00
INDV
-0.05
-0.23%
Supernus Pharmaceuticals, Inc.
USD 41.23
SUPN
-0.23
-0.56%
Biohaven Ltd.
USD 14.74
BHVN
-0.49
-3.22%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%
Key Data
| Date | Operating Cash Flow | Capital Expenditure | Net Cash Used For Investing Activities | Net Cash Used Provided By Financing Activities |
|---|
Competitors
Eli Lilly and Company
USD 625.65
LLY
-15.21
-2.37%
Corcept Therapeutics Incorporated
USD 72.30
CORT
+0.82
1.15%
Jazz Pharmaceuticals plc
USD 111.30
JAZZ
-0.78
-0.70%
SK Biopharmaceuticals Co., Ltd.
USD 71.31
326030.KS
-0.30
-0.42%
H. Lundbeck A/S
USD 5.44
HLUN-B.CO
+0.01
0.19%
Axsome Therapeutics, Inc.
USD 104.80
AXSM
+0.48
0.46%
Alkermes plc
USD 26.71
ALKS
+0.11
0.41%
ACADIA Pharmaceuticals Inc.
USD 24.60
ACAD
+0.20
0.82%
Indivior PLC
USD 22.00
INDV
-0.05
-0.23%
Supernus Pharmaceuticals, Inc.
USD 41.23
SUPN
-0.23
-0.56%
Biohaven Ltd.
USD 14.74
BHVN
-0.49
-3.22%
AbbVie Inc.
USD 198.05
ABBV
-0.81
-0.41%
Roche Holding AG
USD 318.77
RO.SW
-3.47
-1.08%
AstraZeneca PLC
USD 150.15
AZN.L
-2.01
-1.32%
Novartis AG
USD 116.31
NOVN.SW
+1.16
1.00%